These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2964559)

  • 1. The effects of felodipine and bepridil on calcium-stimulated calmodulin binding and calcium pumping ATPase of cardiac sarcolemma before and after removal of endogenous calmodulin.
    Lamers JM; Verdouw PD; Mas-Oliva J
    Mol Cell Biochem; 1987 Dec; 78(2):169-76. PubMed ID: 2964559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase.
    Lamers JM; Cysouw KJ; Verdouw PD
    Biochem Pharmacol; 1985 Nov; 34(21):3837-43. PubMed ID: 2933041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes.
    Walsh MP; Sutherland C; Scott-Woo GC
    Biochem Pharmacol; 1988 Apr; 37(8):1569-80. PubMed ID: 2833901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes.
    Agre P; Virshup D; Bennett V
    J Clin Invest; 1984 Sep; 74(3):812-20. PubMed ID: 6088585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ca2+-pumping ATPase of heart sarcolemma. Characterization, calmodulin dependence, and partial purification.
    Caroni P; Carafoli E
    J Biol Chem; 1981 Apr; 256(7):3263-70. PubMed ID: 6451626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calmodulin-dependent Ca2+-pump ATPase of human smooth muscle sarcolemma.
    Popescu LM; Ignat P
    Cell Calcium; 1983 Oct; 4(4):219-35. PubMed ID: 6315240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Ca2+-dependent protein kinase and Ca2+/Mg2+-ATPase in cardiac sarcolemma by the anti-calmodulin drug calmidazolium.
    Lamers JM; Stinis JT
    Cell Calcium; 1983 Oct; 4(4):281-94. PubMed ID: 6139171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bepridil and cetiedil reversibly inhibit thyroid hormone stimulation in vitro of human red cell Ca2+-ATPase activity.
    Dube MP; Davis FB; Davis PJ; Blas SD
    Mol Endocrinol; 1987 Feb; 1(2):168-71. PubMed ID: 2970587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ca2+-calmodulin-dependent phosphorylation and passive transport of Ca2+ in the myocardial sarcolemma].
    Vorobets ZD; Kurskiĭ MD; Marchenko SN
    Biokhimiia; 1984 Aug; 49(8):1268-74. PubMed ID: 6149768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct mechanisms of inhibition of purified cardiac sarcolemma Ca(2+)-ATPase by two calmodulin antagonists.
    Pasa TC; Otero A; Barrabin H; Scofano HM
    Biochem Pharmacol; 1992 Apr; 43(8):1797-803. PubMed ID: 1533519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel blocker inhibition of the calmodulin-dependent effects of thyroid hormone and milrinone on rabbit myocardial membrane Ca2+-ATPase activity.
    Warnick PR; Davis FB; Mylotte KM; Davis PJ; Dube MP; Blas SD
    Biochem Pharmacol; 1988 Jul; 37(13):2619-23. PubMed ID: 2968801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of canine cardiac sarcoplasmic reticulum Ca2+ uptake by dihydropyridine Ca2+ antagonists.
    Movsesian MA; Ambudkar IS; Adelstein RS; Shamoo AE
    Biochem Pharmacol; 1985 Jan; 34(2):195-201. PubMed ID: 3155615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C mediated activation and phosphorylation of Ca(2+)-pump in cardiac sarcolemma.
    Qu Y; Torchia J; Sen AK
    Can J Physiol Pharmacol; 1992 Sep; 70(9):1230-5. PubMed ID: 1337308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further characterization and reconstitution of the purified Ca2+-pumping ATPase of heart sarcolemma.
    Caroni P; Zurini M; Clark A; Carafoli E
    J Biol Chem; 1983 Jun; 258(12):7305-10. PubMed ID: 6223026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-dependent effects of bepridil on Ca2+-extrusion across rat heart sarcolemma.
    Van Amsterdam FT; Zaagsma J
    Arch Int Pharmacodyn Ther; 1989; 298():90-5. PubMed ID: 2787975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium transport systems in cardiac sarcolemma and their regulation by the second messengers cyclic AMP and calcium-calmodulin.
    Lamers JM
    Gen Physiol Biophys; 1985 Apr; 4(2):143-54. PubMed ID: 2993098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two site binding of bepridil and modulation of adenylate cyclase in cardiac sarcolemmal membranes.
    Cramb G; Dow JW
    Biochim Biophys Acta; 1983 Dec; 736(1):99-108. PubMed ID: 6317030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ca2+-pumping ATPase in skeletal muscle sarcolemma. Calmodulin dependence, regulation by cAMP-dependent phosphorylation, and purification.
    Michalak M; Famulski K; Carafoli E
    J Biol Chem; 1984 Dec; 259(24):15540-7. PubMed ID: 6150938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of sodium-calcium exchange in cardiac sarcolemmal membrane vesicles. 2. Mechanism of inhibition by bepridil.
    Garcia ML; Slaughter RS; King VF; Kaczorowski GJ
    Biochemistry; 1988 Apr; 27(7):2410-5. PubMed ID: 3260109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sarcolemmal Ca2+-ATPase of the ischemic-reperfused myocardium: protective effect of hypocalcemia on calmodulin-stimulated activity.
    Samouilidou EC; Karli JN; Levis GM; Darsinos JT
    Life Sci; 1998; 62(1):29-36. PubMed ID: 9444965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.